These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10666457)

  • 21. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
    Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
    Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
    Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
    Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
    Taniguchi Y; Sasaki S
    Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective attachment of a microtubule interacting peptide to plasmid DNA via a triplex forming oligonucleotide for transfection improvement.
    Girardin C; Maze D; Gonçalves C; Le Guen YT; Pluchon K; Pichon C; Montier T; Midoux P
    Gene Ther; 2023 Apr; 30(3-4):271-277. PubMed ID: 35794469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription.
    Bianchi N; Rutigliano C; Passadore M; Tomassetti M; Pippo L; Mischiati C; Feriotto G; Gambari R
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):919-27. PubMed ID: 9307046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment.
    Brunet E; Corgnali M; Cannata F; Perrouault L; Giovannangeli C
    Nucleic Acids Res; 2006; 34(16):4546-53. PubMed ID: 16951289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progesterone decreases DNA binding factor activity and the expression in Xenopus oocytes of a cAMP responsive gene from rat liver.
    Williams JA; Schlichter D; Wicks WD
    Second Messengers Phosphoproteins; 1988-1989; 12(5-6):261-70. PubMed ID: 2978791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site-directed inhibition of DNA replication by triple helix formation.
    Diviacco S; Rapozzi V; Xodo L; Helene C; Quadrifoglio F; Giovannangeli C
    FASEB J; 2001 Dec; 15(14):2660-8. PubMed ID: 11726542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triplex formation inhibits HER-2/neu transcription in vitro.
    Ebbinghaus SW; Gee JE; Rodu B; Mayfield CA; Sanders G; Miller DM
    J Clin Invest; 1993 Nov; 92(5):2433-9. PubMed ID: 7901237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of triplex DNA-mediated inhibition of transcription initiation in cells.
    Jain A; Magistri M; Napoli S; Carbone GM; Catapano CV
    Biochimie; 2010 Mar; 92(3):317-20. PubMed ID: 20045441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted degradation of mRNA in Xenopus oocytes and embryos directed by modified oligonucleotides: studies of An2 and cyclin in embryogenesis.
    Dagle JM; Walder JA; Weeks DL
    Nucleic Acids Res; 1990 Aug; 18(16):4751-7. PubMed ID: 1697675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new approach to overcome potassium-mediated inhibition of triplex formation.
    Svinarchuk F; Cherny D; Debin A; Delain E; Malvy C
    Nucleic Acids Res; 1996 Oct; 24(19):3858-65. PubMed ID: 8871568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene activation by triplex-forming oligonucleotide coupled to the activating domain of protein VP16.
    Kuznetsova S; Ait-Si-Ali S; Nagibneva I; Troalen F; Le Villain JP; Harel-Bellan A; Svinarchuk F
    Nucleic Acids Res; 1999 Oct; 27(20):3995-4000. PubMed ID: 10497263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.
    Brunet E; Corgnali M; Perrouault L; Roig V; Asseline U; Sørensen MD; Babu BR; Wengel J; Giovannangeli C
    Nucleic Acids Res; 2005; 33(13):4223-34. PubMed ID: 16049028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of triplex-forming oligonucleotides and adenoviral constructs for studying the regulation of gene expression.
    Shamsul Hoque AT; Panyutin IG; Baum BJ
    Methods; 1999 Jul; 18(3):266-72. PubMed ID: 10454984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of c-Ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells.
    Cogoi S; Suraci C; Del Terra E; Diviacco S; van der Marel G; van Boom J; Quadrifoglio F; Xodo L
    Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):283-95. PubMed ID: 10984122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of firefly luciferase gene in Xenopus laevis oocyte.
    Jin Z; Lu D; Huang H; Wang H; Pei W; Luo L
    Chin J Biotechnol; 1991; 7(4):279-84. PubMed ID: 1824240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the human androgen receptor gene with platinated triplex-forming oligonucleotides.
    Graham MK; Brown TR; Miller PS
    Biochemistry; 2015 Apr; 54(13):2270-82. PubMed ID: 25768916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigene-block strategy: effective regulation of gene expression by 2',4'-BNA-modified TFOs with an additional stem-loop structure.
    Tsuda N; Matsumoto A; Ito A; Uneda T; Tanabe A; Obika S; Imanishi T
    Nucleic Acids Symp Ser (Oxf); 2005; (49):335-6. PubMed ID: 17150770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical modification of triplex-forming oligonucleotide to promote pyrimidine motif triplex formation at physiological pH.
    Torigoe H; Nakagawa O; Imanishi T; Obika S; Sasaki K
    Biochimie; 2012 Apr; 94(4):1032-40. PubMed ID: 22245184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.